Literature DB >> 9083293

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

P A van Setten1, V W van Hinsbergh, T J van der Velden, N C van de Kar, M Vermeer, J D Mahan, K J Assmann, L P van den Heuvel, L A Monnens.   

Abstract

In the pathogenesis of the hemolytic uremic syndrome (HUS), endothelial damage of glomeruli and arterioles of the kidney appears to play a central role. Previous studies have shown that verocytotoxin-1 (VT-1) cytotoxicity on human vein endothelial cells require additional stimuli, in particular the inflammatory mediator tumor necrosis factor alpha (TNF alpha). In this study the effects of VT on human glomerular microvascular endothelial cells (GMVEC) were examined. A reproducible method was developed for the isolation and purification of large numbers of highly purified GMVEC. The obtained GMVEC were over 99% pure; their endothelial origin was demonstrated by the expression of the endothelial antigens von Willebrand factor, EN-4, PECAM-1 and V,E-cadherin. Upon stimulation with TNF alpha the cells expressed the endothelial-specific adhesion molecule E-selectin. A limited number of fenestral structures was observed by scanning electron microscopy (SEM), suggesting glomerular origin of the endothelial cells. Cytotoxicity of VT-1 to GMVEC was evaluated by determination of the number of viable adherent cells and by assay of overall protein synthesis after exposure to varying concentrations of VT-1. In non-stimulated GMVEC, cytotoxicity of VT-1 was inversely related to the degree and duration of confluence, subconfluent cells being the most sensitive. In highly confluent GMVEC, VT cytotoxicity required pre-exposure of the cells to the inflammatory mediator TNF alpha, which induced an increase in the number of VT receptors on GMVEC. Thin layer chromatography of extracted glycolipids from the GMVEC showed binding of VT-1 to globotriaosylceramide (Gb3), known to be the functional receptor for VT. There were no major differences in protein synthesis inhibition with equal concentrations VT-1 and VT-2. In conclusion, in this study we provide a reproducible method to isolate, purify and culture well characterized human GMVEC on a routine basis. In vitro studies with these GMVEC demonstrate that VT cytotoxicity depends on the degree of confluence and the additional preexposure to the inflammatory mediator TNF alpha. These observations provide further insight into the complex events that may occur in glomeruli in the pathogenesis of HUS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083293     DOI: 10.1038/ki.1997.170

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

1.  Shiga Toxin-Producing Escherichia coli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Authors:  Lisa M Harrison; Christel van den Hoogen; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Authors:  Hui Du; Haiyi Liu; Jun Zhao; Yuanyuan Wu; Xun Gong; Qiong Zhou; Jingjing Xu; Yuqi Li; Xinwei Shi; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

Review 5.  Advances in haemolytic uraemic syndrome.

Authors:  C M Taylor; L A Monnens
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

6.  Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Authors:  Zuhal Ergonul; Frederic Clayton; Agnes B Fogo; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

7.  Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.

Authors:  Pamela Cameron; Susan J Smith; Mark A Giembycz; Dino Rotondo; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

8.  Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.

Authors:  Verónica I Landoni; Marcelo de Campos-Nebel; Pablo Schierloh; Cecilia Calatayud; Gabriela C Fernandez; M Victoria Ramos; Bárbara Rearte; Marina S Palermo; Martín A Isturiz
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

9.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

10.  Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.

Authors:  Pamela Cameron; Deborah Bingham; Andrew Paul; Martin Pavelka; Scott Cameron; Dino Rotondo; Robin Plevin
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.